HPV Vaccination Study in Postpartum Women
Launched by JOHNS HOPKINS UNIVERSITY · Feb 14, 2020
Trial Information
Current as of June 09, 2025
Completed
Keywords
ClinConnect Summary
This is a pilot, non-inferiority clinical trial using historical controls. Participants will have whole blood drawn at 0 months, 6 months, and 7 months and receive the HPV vaccine at 0 months, 6 months, and 12 months. Each blood draw will consist of one 15mL red top tube to measure HPV serologies and hormone levels. All blood samples collected will be analyzed at the end of the study.
Gender
FEMALE
Eligibility criteria
- Inclusion Criteria:
- • Participants biologically born as females between the ages of 15 through 45 who have delivered a live born baby within the past 72 hours.
- Exclusion Criteria:
- • Pregnancy
- • Severe allergic reaction to vaccine components
- • Prior receipt of an HPV vaccine dose
- • Fetal demise or stillbirth
- • Allergy to latex or yeast
- • Moderate or severe acute illness (deemed by the investigator to exclude)
- • Immunosuppression (e.g., HIV, solid organ transplant).
About Johns Hopkins University
Johns Hopkins University, a prestigious research institution located in Baltimore, Maryland, is renowned for its commitment to advancing medical science and public health through innovative clinical trials. With a rich history of groundbreaking research and a multidisciplinary approach, the university's clinical trial initiatives focus on translating scientific discoveries into effective treatments and interventions. Leveraging state-of-the-art facilities and a collaborative network of experts, Johns Hopkins University conducts rigorous clinical studies that aim to improve patient outcomes and address critical health challenges. Its dedication to ethical standards and participant safety underscores its role as a leader in clinical research.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Baltimore, Maryland, United States
Baltimore, Maryland, United States
Patients applied
Trial Officials
Jenell Coleman, MD
Principal Investigator
Johns Hopkins University
Chailee Moss, MD
Principal Investigator
Johns Hopkins University
Betty Chou, MD
Principal Investigator
Johns Hopkins University
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials